• 03/10/2025

Prologue Journal

Understanding current events through the lenses of the past and future.

Israel

Former Pfizer R&D chief Mikael Dolsten joins Immunai’s board of directors

Jerusalem Post

Tel Aviv startup Immunai aim to map the immune system (photo credit: Courtesy)
Dolsten brings decades of pharmaceutical leadership to advance AI-driven drug discovery.

https://www.jpost.com/business-and-innovation/article-845284